- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Phospho-KDR pY996 Antibody / Phospho-VEGFR2 Antibody recognizes KDR/VEGFR2 when phosphorylated at tyrosine 996. KDR, also known as vascular endothelial growth factor receptor 2, VEGFR2 and CD309, is a receptor tyrosine kinase that serves as a major mediator of vascular endothelial growth factor signaling. Phosphorylation of intracellular tyrosine residues accompanies receptor activation and helps regulate downstream signaling events controlling vascular and endothelial cell biology.
VEGFR2 contains an extracellular ligand-binding region, a single transmembrane segment and an intracellular split tyrosine kinase domain. VEGF binding promotes receptor dimerization and kinase activation, resulting in phosphorylation of multiple intracellular tyrosine residues. These phosphorylation events create regulatory and protein-interaction sites that connect activated VEGFR2 with signaling networks controlling endothelial cell proliferation, migration, survival and vascular permeability.
Tyrosine 996 is located within the intracellular kinase region of VEGFR2. Phosphorylation-specific recognition of this site enables researchers to examine a phosphorylated population of the receptor rather than total KDR abundance. A Phospho-VEGFR2 Antibody can therefore complement antibodies against total VEGFR2 when investigating changes in receptor phosphorylation that occur without corresponding changes in overall protein expression.
VEGFR2 phosphorylation is relevant to studies of angiogenesis, endothelial signaling and vascular development. The VEGF-KDR signaling axis is also extensively investigated in cancer because increased VEGF signaling can support development of tumor-associated vasculature. Abnormal VEGFR2 activity is additionally relevant to pathological processes involving altered vascular growth or permeability, making phosphorylation-specific reagents useful for studying receptor signaling state.
NSJ Bioreagents offers this phospho-specific reagent for research into KDR activation and VEGF-dependent signal transduction. The Phospho-KDR pY996 Antibody terminology identifies both the receptor and targeted phosphorylation site, while Phospho-VEGFR2 Antibody reflects the widely recognized receptor designation.
A Phospho-KDR pY996 Antibody provides a phosphorylation-specific reagent for investigating KDR phosphorylation at Tyr996, while a Phospho-VEGFR2 Antibody supports research into VEGF receptor activation, angiogenesis and endothelial signaling.
For another antibody targeting the same receptor, see our VEGFR2 Antibody / KDR Polyclonal Antibody.
Titration of the Phospho-KDR pY996 Antibody / Phospho-VEGFR2 Antibody may be required due to differences in protocols and secondary/substrate sensitivity.
This Phospho-KDR pY996 Antibody was produced from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding pY996 of human KDR/FLK1.
Aliquot the Phospho-KDR pY996 Antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Phospho-VEGFR2 antibody, VEGFR2 pY996 antibody, KDR pY996 antibody, Phospho-CD309 antibody, Phospho-VEGF Receptor 2 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.